The issue-focused, peer-reviewed article illustrates how pharmacogenetics promises drugs specific to an individual’s condition. However, it poses some ethical concerns: invasion of medical privacy, unequal distribution of benefits, discrimination because it involves genetic tests, and research/business conflict-of-interest.